Copyright
©The Author(s) 2021.
World J Clin Cases. Jul 26, 2021; 9(21): 5812-5821
Published online Jul 26, 2021. doi: 10.12998/wjcc.v9.i21.5812
Published online Jul 26, 2021. doi: 10.12998/wjcc.v9.i21.5812
Figure 1 Overview of the inclusion process of the study population.
CHB: Chronic hepatitis B; HBeAg: Hepatitis B e antigen; HBsAg: Hepatitis B surface antigen.
- Citation: Tan N, Luo H, Kang Q, Pan JL, Cheng R, Xi HL, Chen HY, Han YF, yang YP, Xu XY. Soluble programmed death-1 is predictive of hepatitis B surface antigen loss in chronic hepatitis B patients after antiviral treatment. World J Clin Cases 2021; 9(21): 5812-5821
- URL: https://www.wjgnet.com/2307-8960/full/v9/i21/5812.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i21.5812